Vaccination Response in immunoCompromised Host 2.

Completed

• Conditions: HIV, hemodialysis, bonemarrow transplant, reumatologic patients, lung transplant patients.

• Registration Number: NL-OMON26830
• Lead Sponsor: /A

Brief Summary

/A

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 28 February 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 580

Inclusion Criteria

Immunocompromized patients at least 18 years of age.

Exclusion Criteria

1. Active infection;

2. Pregnancy;

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
GMT 30 days post vaccination.

Secondary Outcome Measures

Name	Time	Method
Protection rates.